Approval · Notice of Compliance 10202 · 2009
BICALUTAMIDE TABLETS: Notice of Compliance 10202
Issued May 12, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10202
- Date
- May 12, 2009
- Company
- Accord Healthcare IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Non-steroidal antiandrogen
- Canadian reference product
- CASODEX (Astrazeneca Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BICALUTAMIDE TABLETS | 02325985 | Marketed |
Medicinal ingredients
- BICALUTAMIDE 50 MG per TAB